Highly efficient expression of Rasamsonia emersonii lipase in Pichia pastoris : characterization and gastrointestinal simulated digestion in vitro
Journal of the Science of Food and Agriculture · 2024
DOI: 10.1002/jsfa.13390 ↗At a glance
Journal article in Journal of the Science of Food and Agriculture, 2024. Written by Buqing Wang and 5 co-authors. Institution: Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China. Major MEDLINE topics: Digestion, Fungal Proteins, Lipase, Pichia. Cited 3 times so far (Crossref); 46 references. Funded by: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province, Shandong Provincial Major Scientific and Technological Innovation Project.
Abstract (original language)
BACKGROUND Acidic lipases with high catalytic activities under acidic conditions have important application values in the food, feed and pharmaceutical industries. However, the availability of acidic lipases is still the main obstacle to their industrial applications. Although a novel acidic lipase Rasamsonia emersonii (LIPR) was heterologously expressed in Escherichia coli , the expression level was unsatisfactory. RESULTS To achieve the high‐efficiency expression and secretion of LIPR in Pichia pastoris GS115, the combinatorial optimization strategy was adopted including gene codon preference, signal peptide, molecular chaperone co‐expression and disruption of vacuolar sorting receptor VPS10 . The activity of the combinatorial optimization engineered strain in a shake flask reached 1480 U mL −1 , which was 8.13 times greater than the P. pastoris GS115 parental strain. After high‐density fermentation in a 5‐L bioreactor, the highest enzyme activity reached as high as 11 820 U mL −1 . LIPR showed the highest activity at 40 °C and pH 4.0 in the presence of Ca 2+ ion. LIPR exhibited strong tolerance to methanol, indicating its potential application in biodiesel biosynthesis. Moreover, the gastrointestinal digestion simulation results demonstrated that LIPR was tolerant to pepsin and trypsin, but its activity was inhibited by sodium taurodeoxycholate. CONCLUSION This study provided an effective approach for the high expression of acidic lipase LIPR. LIPR was more appropriate for lipid digestion in the stomach than in intestine according to the gastrointestinal digestion simulation results. © 2024 Society of Chemical Industry.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi, China.
- State Key Laboratory of Biochemical Engineering, Institute of Process Engineering, Chinese Academy of Sciences, Beijing, China.
- Institute for Glyco-Core Research, Gifu University, Gifu, Japan.
ORCID profiles: Zijie Li
Funding
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangsu Province
- Shandong Provincial Major Scientific and Technological Innovation Project
Cite
APA
Wang, B., Wang, Y., Zhou, X., Gao, X. D., Fujita, M., & Li, Z. (2024). Highly efficient expression of Rasamsonia emersonii lipase in Pichia pastoris : characterization and gastrointestinal simulated digestion in vitro. Journal of the Science of Food and Agriculture. https://doi.org/10.1002/jsfa.13390
Vancouver
Wang B, Wang Y, Zhou X, Gao XD, Fujita M, Li Z. Highly efficient expression of Rasamsonia emersonii lipase in Pichia pastoris : characterization and gastrointestinal simulated digestion in vitro. Journal of the Science of Food and Agriculture. 2024. doi:10.1002/jsfa.13390
BibTeX
@article{Wang2024,
author = {Wang, Buqing and Wang, Yasen and Zhou, Xiaoman and Gao, Xiao-Dong and Fujita, Morihisa and Li, Zijie},
title = {Highly efficient expression of Rasamsonia emersonii lipase in Pichia pastoris : characterization and gastrointestinal simulated digestion in vitro},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
doi = {10.1002/jsfa.13390}
}
EUVIMED